Graft failure after allogeneic hematopoietic stem cell transplantation: Definition and risk factors

被引：1
|
作者：
Alcazer, Vincent [1 ,2 ]
de Latour, Regis Peffault [3 ,4 ]
Ader, Florence [5 ,6 ]
Labussiere-Wallet, Helene [1 ]
机构：
[1] Hosp Civils Lyon, Dept Hematol Clin, 165 Chemin Grand Revoyet, F-69310 Pierre Benite, France
[2] Ctr Rech Cancerol Lyon, Inserm U1052, CNRS 5286, F-69008 Lyon, France
[3] Hop St Louis, AP HP, Serv Hematol Greffe, F-75006 Paris, France
[4] Univ Paris Diderot, F-75007 Paris, France
[5] Hosp Civils Lyon, Serv Malad Infect, F-69004 Lyon, France
[6] Ctr Int Rech Infectiol, Inserm U1111, CNRS 5308, F-69008 Lyon, France
来源：
BULLETIN DU CANCER | 2019年 / 106卷 / 06期
关键词：
Allogeneic hematopoietic; stem cell transplantation; Graft failure; Rejection; Infections; ANTI-HLA ANTIBODIES; BONE-MARROW-TRANSPLANTATION; PERIPHERAL-BLOOD; RETROSPECTIVE ANALYSIS; FRANCOPHONE SOCIETY; APLASTIC-ANEMIA; DONOR; IMPACT; OUTCOMES; ENGRAFTMENT;
D O I：
10.1016/j.bulcan.2019.03.009
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Allogeneic hematopoietic stem cell transplantation is the only curative therapy for numerous malignant and non-malignant haematological diseases. A sustained engraftment of the donor stem cells is essential for transplant success and overall outcome. Graft failure is a rare but severe event after allogeneic hematopoietic stem cell transplantation. While different risk factors such as underlying disease, graft source or HLA matching have been found to be consistently associated with graft failure, other factors such as ABO mismatch graft-versus-host disease prophylaxis or infections, particularly viral reactivations, are more controversial. In this article, we review the different factors associated with graft failure.
引用
收藏
页码：574 / 583
页数：10
相关论文
共 50 条
  • [41] Outcome of graft failure after allogeneic stem cell transplant: study of 89 patients
    Ferra, Christelle
    Sanz, Jaime
    Diaz-Perez, Miguel-Angel
    Morgades, Mireia
    Gayoso, Jorge
    Cabrera, Jose-Rafael
    Villaescusa, Teresa
    Sampol, Maria-Antonia
    Fernandez-Aviles, Francesc
    Solano, Carlos
    Ortin, Miguel
    Duarte, Rafael
    Cuesta, Marian
    Heras, Inmaculada
    de la Serna, Javier
    Moraleda, Jose-Maria
    Barrenetxea, Cristina
    Gonzalez-Vicent, Marta
    Sanz, Guillermo
    Ribera, Josep-Maria
    LEUKEMIA & LYMPHOMA, 2015, 56 (03) : 656 - 662
  • [42] Role of interferon-γ in immune-mediated graft failure after allogeneic hematopoietic stem cell transplantation
    Merli, Pietro
    Caruana, Ignazio
    De Vito, Rita
    Strocchio, Luisa
    Weber, Gerrit
    Del Bufalo, Francesca
    Buatois, Vanessa
    Montanari, Paolo
    Cefalo, Maria Giuseppina
    Pitisci, Angela
    Algeri, Mattia
    Galaverna, Federica
    Quintarelli, Concetta
    Cirillo, Valentina
    Pagliara, Daria
    Ferlin, Walter
    Ballabio, Maria
    De Min, Cristina
    Locatelli, Franco
    HAEMATOLOGICA, 2019, 104 (11) : 2314 - 2323
  • [43] Outcomes of salvage haploidentical transplantation using posttransplant cyclophosphamide for graft failure following allogeneic hematopoietic stem cell transplantation
    Kaito Harada
    Yuho Najima
    Motohiro Kato
    Shigeo Fuji
    Akihito Shinohara
    Hirohisa Nakamae
    Masako Toyosaki
    Miho Ashiarai
    Makoto Onizuka
    Yoshiko Hashii
    Tatsuo Ichinohe
    Yoshiko Atsuta
    Hideki Nakasone
    International Journal of Hematology, 2022, 116 : 744 - 753
  • [44] Specific factors influence the success of autologous and allogeneic hematopoietic stem cell transplantation
    Goncalves, Thissiane L.
    Benvegnu, Dalila M.
    Bonfanti, Gabriela
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2009, 2 (02) : 82 - 87
  • [45] Secondary haploidentical hematopoietic stem cell transplantation in patients with relapse or graft failure after initial hematopoietic stem cell transplantation
    Hou, Chang
    Chen, Nan
    Jiang, Shuhui
    Chen, Sifan
    Fan, Yi
    Chen, Jia
    Wang, Ying
    Xu, Yang
    Wu, Depei
    ANNALS OF HEMATOLOGY, 2019, 98 (12) : 2833 - 2836
  • [46] Management of dyslipidemia after allogeneic hematopoietic stem cell transplantation
    Lu, Yingxue
    Ma, Xiaojing
    Pan, Jie
    Ma, Rongqiang
    Jiang, Yujie
    LIPIDS IN HEALTH AND DISEASE, 2022, 21 (01)
  • [47] Significance of graft quality in allogeneic hematopoietic stem cell transplantation
    Jinca, Cristian
    Arghirescu, Smaranda
    Oprisoni, Andrada
    Balint-Gib, Loredana
    Baica, Mihaela
    Serban, Margit
    REVISTA ROMANA DE MEDICINA DE LABORATOR, 2009, 16 (03): : 21 - 27
  • [48] Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation
    Landgren, Ola
    Gilbert, Ethel S.
    Rizzo, J. Douglas
    Socie, Gerard
    Banks, Peter M.
    Sobocinski, Kathleen A.
    Horowitz, Mary M.
    Jaffe, Elaine S.
    Kingma, Douglas W.
    Travis, Lois B.
    Flowers, Mary E.
    Martin, Paul J.
    Deeg, H. Joachim
    Curtis, Rochelle E.
    BLOOD, 2009, 113 (20) : 4992 - 5001
  • [49] Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
    Remberger, M
    Kumlien, G
    Aschan, J
    Barkholt, L
    Hentschke, P
    Ljungman, P
    Mattsson, J
    Svennilson, J
    Ringdén, O
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2002, 8 (12) : 674 - 682
  • [50] Risk factors and outcome of graft failure after HLA matched and mismatched unrelated donor hematopoietic stem cell transplantation: a study on behalf of SFGM-TC and SFHI
    Cluzeau, T.
    Lambert, J.
    Raus, N.
    Dessaux, K.
    Absi, L.
    Delbos, F.
    Devys, A.
    De Matteis, M.
    Dubois, V.
    Filloux, M.
    Fort, M.
    Hau, F.
    Jollet, I.
    Labalette, M.
    Masson, D.
    Mercier, B.
    Pedron, B.
    Perrier, P.
    Picard, C.
    Quainon, F.
    Ramounau-Pigot, A.
    Renac, V.
    Van Endert, P.
    Charron, D.
    de la Tour, R. Peffault
    Taupin, J. L.
    Loiseau, P.
    BONE MARROW TRANSPLANTATION, 2016, 51 (05) : 687 - 691
12345